Interviews

Proven medical device and health technology experts will show you how to improve your sales & marketing efforts, enhance your regulatory submissions, raise venture capital, and much more.

Latest

Check out the most recent interviews with world-class medical device and health technology founders and CEOs.

Go Premium
Premium

Crowdfunding and IPOs for Medtech Startups

Interview with Monogram Orthopedics CEO Benjamin Sexson

Benjamin Sexson is the President and CEO of Monogram Orthopedics. He is a mechanical engineer from Caltech and a CFA charterholder. At Monogram, Ben and his team are developing a fully autonomous robotic system for knee replacement surgery. In this interview, Ben talks about the importance of a good team and a liberating company culture as well as the importance of believing in what you’re doing and openly reassessing its validity regularly. He also elaborates on Monogram’s daring strategies for validating its technology and walks us through the pros and cons of crowdfunding and going public.

Premium

How to Innovate in Medtech with Limited Means

Interview with Field Medical CEO Dr. Steven Mickelsen

Dr. Steven Mickelsen is a practicing electrophysiologist who’s leveraging his clinical expertise and entrepreneurial spirit to revolutionize cardiac care. He made significant strides ushering in pulse field ablation (PFA) technology into the field through one of his previous companies Farapulse, which sold to Boston Scientific. Today, as CEO of Field Medical, he continues to contribute to the space by developing the next generation of PFA for ventricular arrhythmia management. In this episode, he shares his hard-earned wisdom on how limited means can breed resourcefulness, how to build a modest yet effective prototype, why having real expertise in clinical and regulatory spheres is a necessity, and how to raise funds with a win-win mindset.

Premium

Grit and the Power of Showing Up

Interview with Venture Capitalist Anish Kaushal

Anish Kaushal, a former physician turned healthcare investor and author, shares his unconventional career journey from medicine to VC at Amplitude Ventures. He reveals vital fundraising strategies from an investor's perspective, offers practical tips for crafting pitch decks that capture attention, discusses why always being in the mode of seeking funds is so important, expands on the value of building extensive networks, and talks about the cumulative effect of small improvements. He also provides guidance on staying open and ready for career shifts in today’s fast-paced professional environment as outlined in his latest book.

Premium

The Essentials of Building the Right Foundation

Interview with Neuro42 Co-Founder Abhita Batra

Abhita Batra, co-founder and Chief Strategy Officer at Neuro42, is at the forefront of altering neurological diagnostics for good. The company recently received 510(k) clearance for its portable head and brain MRI system, which integrates MRI, AI, and robotics in one platform. Neuro42's system is a compact, easy-to-use solution for urgent care and clinical settings. In this interview, Abhita talks about her approach to building strategy at early-stage companies, the importance of a good team and thorough market analysis, and how to take a nuanced approach with regulatory bodies.

Premium

Empathy-Driven Innovation

Interview with MOLLI Surgical CEO Ananth Ravi

Under the guidance of Ananth Ravi, MOLLI Surgical has developed an award-winning, wire-free soft tissue localization technology for breast cancer surgery. Their device, MOLLI, precisely marks the location of lesions for removal during surgery and is setting a new standard for patient comfort compared to traditional methods. In this interview, Ananth unpacks his story, touching upon the benefits of being in close contact with a medical ecosystem, the importance of intuitive design, the ideal role of regulatory consultants, and the funding strategies he employs for MOLLI.

Premium

Think Big, Start Small, and Prioritize Ruthlessly

Interview with InterShunt CEO Harlee Sorkin

Harlee Sorkin’s company, InterShunt Technologies, is leading the development of a groundbreaking minimally invasive catheter designed to treat heart failure. The technique they use focuses on creating a shunt within the heart. By improving blood flow and lessening the heart's workload, it holds promise of easing heart failure symptoms, potentially setting a new standard in patient care. In this interview, Harlee delves into the nuances of leading an early-stage medtech company and covers essential topics such as development prioritization and capital fundraising. He also shares what it’s like to navigate clinical and regulatory challenges as a first-time medtech entrepreneur and how to effectively engage with stakeholders across the healthcare ecosystem.

Premium

Get exclusive benefits like full access to the entire archive of Medsider interviews and every Medsider Mentors volume.

Go Premium
Premium

Why Learning Fast Beats Failing Fast

Interview with Portal Instruments CEO Patrick Anquetil

Patrick Anquetil, CEO of Portal Instruments, has extensive experience in guiding bioengineering companies from their nascent stages to market success. At Portal, they are developing a novel needle-free drug delivery system. This cutting-edge technology promises to revolutionize how medications are administered, making the process less invasive, more precise, and more comfortable for patients. In this interview, Patrick talks about how he landed on Portal’s business model, how his team condenses timelines across key company functions, and why their diverse set of partners is a golden asset to the company.

Premium

Taking the Stress Out of Conception

Interview with Béa Fertility CEO Tess Cosad

We sat down with Tess Cosad, a femtech enthusiast and CEO of Béa Fertility. Founded in 2020, Béa offers innovative, hormone-free, accessible, at-home fertility treatments and ovulation tracking as an alternative to traditional clinic-based offerings. Their flagship product simplifies the fertility journey thanks to its user-friendly design. In this interview, Tess delves into the challenges and triumphs of launching a consumer-facing product, the importance of a solid design team, how to be comfortable making decisions with imperfect information, and the lessons she learned about being a CEO while raising funds.

Premium

Building a Startup in a Collaborative Ecosystem

Interview with Noa Therapeutics CEO Carla Spina

In this episode, we sit down with Carla Spina, the pioneering force behind Noa Therapeutics. Carla and her team are developing treatments for inflammatory skin diseases with their innovative multimodal small-molecule therapies. Carla shares her invaluable experiences on the importance of engaging actively with the startup ecosystem and staying connected with those who are shaping the field. We talk about how building a company is a collaborative venture that requires a strong network of entrepreneurs, investors, and industry experts, and the significance of authentic interaction when reaching out to a variety of potential stakeholders.

Premium

Balancing Innovation with Practical Outsourcing

Interview with Spark Biomedical CEO Daniel Powell

Daniel Powel is the CEO of Spark Biomedical, developers of the Sparrow Ascent, a drug-free wearable device to combat opioid withdrawal symptoms. In this interview, Daniel shares key insights from his journey: the importance of testing ideas and creating a MVP, diversifying funding sources, and how to make informed regulatory decisions.

Premium

Shaping the Future of Alzheimer’s Care

Interview with Sinaptica CEO Ken Mariash

Ken Mariash is a leading figure in the neuromodulation space and the CEO of Sinaptica Therapeutics, where his team is developing groundbreaking treatments for Alzheimer's disease. Their device delivers non-invasive neuromodulation therapy to key networks of the brain, and has shown unprecedented improvement in treating this debilitating disease. In our interview, Ken shares his time-tested wisdom, covering a range of topics from kick-starting a venture and how to approach M&A transactions, to mastering commercialization and best practices for engaging with investors.

Premium

Your Network is Your Net Worth

Interview with NeuroOne CEO Dave Rosa

Dave Rosa, President and CEO of NeuroOne, is a seasoned leader in the medical device industry with over thirty years of experience. NeuroOne is developing high-definition, minimally invasive neurology devices utilizing its unique thin-film electrode technology. In this interview, Dave discusses critical strategies to secure initial capital even before early development and regulatory milestones are achieved, how to leverage networks to connect with potential investors; and the importance of assembling a supportive and experienced team, including board members.

Premium

Pioneering AI in Patient Diagnosis

Interview with Digital Diagnostics CEO John Bertrand

John Bertrand is the CEO of Digital Diagnostics, a company that is pioneering AI healthcare systems. Its flagship product, LumineticsCore, is an algorithm that autonomously diagnoses patients with diabetic retinopathy. In our interview, John shares his insights on aligning products with real-world needs, the importance of stakeholder engagement for adoption and long-term success, and strategies for navigating the extended sales cycles in healthcare technology.

Premium

Collaborating for Clinical Credibility

Interview with Strados Labs CEO Nick Delmonico

In this interview Nick Delmonico, the CEO of Strados Labs, a company developing a wearable stethoscope to remotely capture lung sounds, discusses how Strados validated its technology through others' research and how starting with a clear understanding of the problem, rather than jumping straight to offering solutions, created significant opportunities for his company. Nick also emphasizes why interpersonal skills and active listening are crucial to success in medtech, and shares strategies for non-dilutive funding as a way to alleviate initial capital constraints while building credibility at the same time.